MiMedx Group, Inc.
Compositions and methods of treatment with amniotic fluid

Last updated:

Abstract:

The present disclosure provides compositions composed of amniotic fluid and/or modified amniotic fluid, a pharmaceutically acceptable carrier, and optionally a placental tissue graft, micronized placental tissue components, or extracts derived therefrom. Also described are systems and apparatuses for administering or storing said compositions, as well as methods of treatment using said compositions.

Status:
Grant
Type:

Utility

Filling date:

23 Mar 2017

Issue date:

30 Mar 2021